| Medicare CGS | Billing and Coding: Urinary Biomarkers for Chronic Pain Management (59423) | 2026-02-19 |
| Medicare NGS | Billing and Coding: Denosumab (Prolia–, Xgeva–, Jubbonti–, Wyost–, Ospomyv–,Xbryk–,Bomyntra–, Conexxence–, Stoboclo–, Osenvelt–,Bildyos–, Bilprevda–) (52399) | 2026-02-19 |
| Medicare NGS | Billing and Coding: Ranibizumab and biosimilars, Aflibercept, Aflibercept HD, Brolucizumab-dbll, Faricimab-svoa, PAVBLU–aflibercept-ayyh, AHZANTIVE–aflibercept-abzv. ENZEEVU–aflibercept-mrbb, OPUVIZ–aflibercept-yszy and YESAFILI– aflibercept-jbvf (52451) | 2026-02-19 |
| Aetna | Spinal Surgery: Laminectomy and Fusion | 2026-02-18 |
| Aetna | Cardiac Devices and Procedures for Occlusion of the Left Atrial Appendage | 2026-02-18 |
| Aetna | Electric Tumor Treatment Fields | 2026-02-18 |
| Aetna | Clotting Factors | 2026-02-17 |
| Aetna | Bortezomib Products | 2026-02-17 |
| Humana Medicaid | Genetic Testing for Diagnosis of Inherited Conditions - MEDICAID - INDIANA | 2026-02-16 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Outpatient Surgery Site of Care | 2026-02-16 |